Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 20 device-driven procedures, CMS 2024
Not enough data yet.
Not enough data yet.
Share of surgeons' claims in surgery centers and offices.
Not enough data yet.
Today's surgeons with a 50%+ chance of no longer billing it here.
Not enough data yet.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 6 | 114−10%/yr | −10%/yr | 1.00.4× | 0% | 50 in 2030−12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 18 | 1,868−6.3%/yr | −6.3%/yr | 15.90.2× | 33% | 3,090 in 2030+8.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 9 | 412−4.3%/yr | −4.3%/yr | 3.50.5× | 12% | 670 in 2030+8.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 6 | 439+0.5%/yr | +0.5%/yr | 4.00.7× | 0% | 760 in 2030+9.5%/yr |
| Cholecystectomy & appendectomy | 2 | 272−7%/yr | −7%/yr | 2.40.7× | 0% | 430 in 2030+8%/yr |
| Colorectal resection | 0 | 141+1.5%/yr | +1.5%/yr | 1.30.8× | 0% | 150 in 2030+1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 10 | 397+2.4%/yr | +2.4%/yr | 3.50.6× | 0% | 810 in 2030+13%/yr |
| BPH procedures | 3 | 213−6.2%/yr | −6.2%/yr | 1.90.4× | 0% | 320 in 2030+7.2%/yr |
| Hysterectomy, hysteroscopy & ablation | 4 | 193−5.7%/yr | −5.7%/yr | 1.80.5× | 9% | 360 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 13 | 477−0.9%/yr | −0.9%/yr | 4.40.5× | 0% | 1,320 in 2030+18%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 14 | 1,742+68%/yr | +68%/yr | 15.10.5× | 23% | 4,210 in 2030+16%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 10 | 413+2.4%/yr | +2.4%/yr | 3.70.8× | 0% | 710 in 2030+9.3%/yr |
| EP ablation | 6 | 187+11%/yr | +11%/yr | 1.50.4× | 0% | 630 in 2030+22%/yr |
| LAA occlusion & loop recorders | 3 | 103−6.7%/yr | −6.7%/yr | 0.80.3× | 0% | 200 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 8 | 437−6.6%/yr | −6.6%/yr | 3.40.7× | 0% | 790 in 2030+10%/yr |
| Structural heart (TAVR, TEER) | 6 | 189+4.2%/yr | +4.2%/yr | 1.50.8× | 0% | 300 in 2030+7.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 17 | 4,085−6.1%/yr | −6.1%/yr | 35.40.7× | 63% | 6,680 in 2030+8.5%/yr |
| Vitreoretinal surgery | 2 | 101+27%/yr | +27%/yr | 0.90.5× | 0% | 180 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 43 | 7,313−0.6%/yr | −0.6%/yr | 65.80.5× | 14% | 14,500 in 2030+12%/yr |
| Bronchoscopy & lung nodule | 4 | 192+6.8%/yr | +6.8%/yr | 1.70.6× | 0% | 560 in 2030+20%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.